NIH #UH3CA207101
Colorectal Cancer Molecular Subtype Assay Development and Validation
- Amount
- $300K–$400K
- Period
- 2018-09-21 → 2024-08-31
- PIs
- 4
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Dipen M. Maru
Full Professor(heuristic)
Colorectal Cancer Treatments and Studies · Oncology
Compare more Oncology professors.
h-index66
i10-index174
Publications483
Citations16,153
Grants
3 total · 0 active
NIH #P50CA221707
Core 1: Biospecimen and Pathology Core
- Amount
- $200K–$300K
- Period
- 2019-08-20 → 2024-05-31
- PIs
- 1
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #UH2CA207101
Colorectal Cancer Molecular Subtype Assay Development and Validation
- Amount
- $200K–$300K
- Period
- 2018-09-21 → 2020-08-31
- PIs
- 4
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Spatial multi-omics landscape of colorectal cancer macro- and micrometastases (Cancer Cell)2026-07-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-17
Data may not be current
Find elsewhere
ORCID: 0000-0002-9134-7709